RECURSION PHARMACEUTICALS, INC. (RXRX) Net margin 2019–2025
RECURSION PHARMACEUTICALS, INC. (RXRX) net profit margin by fiscal year — reported net income divided by reported revenue.
-863.4%FY2025 · since FY2019: -2668.3% → -863.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -863.4% | -75.3 pp |
| FY2024 | -788.0% | -52.0 pp |
| FY2023 | -736.0% | -134.9 pp |
| FY2022 | -601.0% | +1231.1 pp |
| FY2021 | -1832.2% | +363.8 pp |
| FY2020 | -2196.0% | +472.3 pp |
| FY2019 | -2668.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice